The Dow Jones Industrial Average fell 382.15 points, or 0.86%, to 43,910.98, the S&P 500 lost 17.36 points, or 0.29%, to ...
Richmond Fed President Thomas Barkin said earlier in the day that the U.S. central bank is ready to respond if inflation ...
Major Wall Street indices closed lower on Tuesday as investors booked some profits from a post-election rally and turned ...
Amgen stock price tanked 7%, Novavax shares plunged 6% ... in the day that the US central bank is ready to respond if ...
Hosted on MSN2d
Wall Street dips as focus moves to economic dataThe U.S. central bank is ready to respond if inflation pressures rise or the job market weakens ... despite forecasting a ...
Wall Street's main indexes fell on Tuesday as investors booked profits from post-election gains and awaited U.S. inflation ...
Revenue: US$84.5m (down 55% from 3Q 2023). Net loss: US$121.3m (loss narrowed by 7.2% from 3Q 2023). US$0.76 loss per share ...
Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...
Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Tuesday reported a loss of $121.3 million in its third quarter. On a per-share basis, the Gaithersburg, Maryland-based company ...
Novavax has been gearing up to launch a phase 3 trial of what may result in an important product: A combined flu and coronavirus vaccine. But the company now faces a roadblock, saying regulators ...
In early pandemic days, Novavax (NASDAQ: NVAX) shares soared as investors bet on the company's ability to bring a coronavirus vaccine to market. But as the biotech fell behind in the race and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback